List of Oncology Medication For

Lung Cancer

The most commonly diagnosed type of lung cancer is carcinoma. There are many types of carcinoma-derived lung cancers, but the significant types are classified as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC and NSCLC are the second cancer leaders. In comparison to NSCLC, SCLC can proliferate and form solid tumor masses more rapidly. In contrast with this highly proliferative potential, SCLC is known to be less aggressive than non-small lung malignancies.

If Lung Cancer Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Capmatinib Tablets

Lung Cancer

capmatinib tablets,
for oral use Initial U.S. Approval: 2020

Tabrecta (capmatinib) is a medication used for the treatment of adults with metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14).

Facts about capmatinib tablets

Disease Indications-Lung Cancer
Manufacturer-Novartis Pharmaceuticals Corporation
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “capmatinib tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine)

Lung Cancer, Pneumonia

Brand Name: CAPVAXIVE . Generic Name: (Pneumococcal 21-valent Conjugate Vaccine). It is used to treat pneumonia.

Capvaxive is a vaccine to protect adults against pneumonia (infection of the lungs) and invasive diseases caused by the bacterium Streptococcus pneumoniae (S. pneumoniae).

Brand Name:	CAPVAXIVE
Generic Name:	Pneumococcal 21-valent Conjugate Vaccine
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Cemiplimab-rwlc Injection

Lung Cancer, Skin

cemiplimab-rwlc injection
for intravenous use Initial U.S. Approval: 2018

Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC).

Facts about cemiplimab-rwlc injection

Disease Indications-Lung Cancer, Skin Cancer
Manufacturer-Sanofi
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Cemiplimab-rwlc Injection” based on the information you provide.

Dacomitinib Tablets

Lung Cancer

dacomitinib tablets,
for oral use Initial U.S. Approval: 2018

Vizimpro (dacomitinib) is a medication used for the treatment of patients with metastatic NSCLC with EGFR exon 19 deletion or exon 21 L858R substitution mutations.

Facts about dacomitinib tablets

Disease Indications-Lung Cancer
Manufacturer-Pfizer Limited
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Dacomitinib Tablets” based on the information you provide.

Docetaxel Injection

Prostate, Breast Cancer, Gastrointestinal, Head And Neck, Lung Cancer

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

docetaxel Injection is a prescription anticancer medicine used to treat certain people with: • breast cancer • non-small cell lung cancer • prostate cancer • stomach cancer • head and neck cancer It is not known if TAXOTERE is effective in children. What are the ingredients in TAXOTERE? Active ingredient: docetaxel Inactive ingredients: polysorbate 80 and dehydrated alcohol solution.

Facts about docetaxel Injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): docetaxel Injection
Dosage Forms And Strengths: Injection: One-vial TAXOTERE: Single-dose vials 20 mg/mL and 80 mg/4 mL
Company: sanofi aventis
Current indications:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import docetaxel Injection” based on the information you provide.

Elexacaftor, Tezacaftor, and Ivacaftor tablets

Lung Cancer

elexacaftor, tezacaftor, and ivacaftor tablets; ivacaftor tablets co-packaged for oral use Initial U.S. Approval: 2019

Facts about elexacaftor, tezacaftor, and ivacaftor tablets

Approval Date: 2019
Proprietary Name: On Request
Active Ingredient(s): elexacaftor, tezacaftor, and ivacaftor tablets; ivacaftor tablets
Dosage Forms And Strengths:Fixed-dose combination containing elexacaftor 50 mg, tezacaftor 25 mg and ivacaftor 37.5 mg co-packaged with ivacaftor 75 mg.
Company: Vertex Pharmaceuticals
Disease: Cystic fibrosis
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “elexacaftor, tezacaftor, and ivacaftor tablets” based on the information you provide.

Erlotinib Tablets

Lung Cancer

erlotinib tablets
oral Initial U.S. Approval: 2004

Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.

Facts about erlotinib tablets

Approval Date: 2004
Proprietary Name: On Request
Active Ingredient(s): erlotinib tablets
Dosage Forms And Strengths: Tablets: 25 mg, 100 mg and 150 mg
Company:
Current indications: non-small cell lung cancer (NSCLC)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “erlotinib tablets” based on the information you provide.

Everolimus Tablets

Breast Cancer, Gastrointestinal, Kidney, Lung Cancer

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Gefitinib Tablets

Lung Cancer

gefitinib tablets
for oral use Initial U.S. Approval: 2015

IRESSA is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Facts about gefitinib tablets

Approval Date: 2015
Proprietary Name: On Request
Active Ingredient(s): gefitinib tablets
Dosage Forms And Strengths: Tablets: 250 mg
Company: AstraZeneca
Current indications: non-small cell lung cancer (NSCLC)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “gefitinib tablets” based on the information you provide.

Gemcitabine for injection

Ovarian, Bile Duct Cancer, Breast Cancer, Lung Cancer, Pancreatic

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Lung Cancer

capmatinib tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

Brand Name: CAPVAXIVE . Generic Name: (Pneumococcal 21-valent Conjugate Vaccine). It is used to treat pneumonia.

cemiplimab-rwlc injection for intravenous use Initial U.S. Approval: 2018

Facts about cemiplimab-rwlc injection

Access the best support services globally

dacomitinib tablets, for oral use Initial U.S. Approval: 2018

Facts about dacomitinib tablets

Access the best support services globally

docetaxel Injection for intravenous use Initial U.S. Approval: 1996

Facts about docetaxel Injection

Access the best support services globally

elexacaftor, tezacaftor, and ivacaftor tablets; ivacaftor tablets co-packaged for oral use Initial U.S. Approval: 2019

Facts about elexacaftor, tezacaftor, and ivacaftor tablets

Access the best support services globally

erlotinib tablets oral Initial U.S. Approval: 2004

Facts about erlotinib tablets

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

gefitinib tablets for oral use Initial U.S. Approval: 2015

Facts about gefitinib tablets

Access the best support services globally

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

capmatinib tablets,
for oral use Initial U.S. Approval: 2020

cemiplimab-rwlc injection
for intravenous use Initial U.S. Approval: 2018

dacomitinib tablets,
for oral use Initial U.S. Approval: 2018

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

erlotinib tablets
oral Initial U.S. Approval: 2004

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

gefitinib tablets
for oral use Initial U.S. Approval: 2015